Members of the Oval and SMC Ltd. team will be attending the Drug Delivery Partnership (DDP) conference in Palm Beach Gardens, FL February 7-9, 2017.   If you or someone you know is attending and would like to learn about the next generation of auto injectors, manufacturing scale-up, or production of combination products please let…

Oval and SMC Ltd. will be exhibiting at Pharmapack Europe in Paris, France.   Visit us at booth #L24 to meet members of our Oval Medical Technologies team and learn about the next generation of auto injectors, manufacturing scale-up, and production of combination products.

[button link=”http://www.ovalmedical.com/wp-content/uploads/2016/12/SMCLtd_Oval_121316v3.pdf” bg_color=”#40b4e5″ window=”yes”]Download PDF[/button] Somerset, Wisconsin – SMC Ltd., a global contract manufacturer of pharmaceutical and finished medical devices, announced today that it has acquired Oval Medical Technologies Ltd., a specialty pharmaceutical device company developing next generation autoinjectors based in Cambridge, UK.   Oval’s autoinjector platforms address the unmet needs in the self-injection market…

Oval Medical representatives Matthew Young (CTO), Pete Evans (Dir. Device Development) and Bastiaan de Leeuw (Dir. Business Development) will attend Pharmapack Europe (Paris, 10-11 Feb 2016). Our autoinjector products will be on display at booth #537 of our Japanese partner company Solize. If you would like to set up an appointment with one of us,…

Barbara Lead (CEO) and Matthew Young (CTO) will be present at Biotech Showcase 2016 from Jan 11th-13th (https://lnkd.in/e7-gUTh) in San Francisco. To arrange to meet them you can contact us via our Contact page.

Oval Medical’s CEO, Ms Barbara Lead will be one of the panellists in the Industry Roundtable “Drugs, Delivery, and Patients – How Will We Bring It All Together in the New World?” at the Annual Meeting of the Controlled Release Society on Sunday July 26th. The panel discussion, moderated by Ms Debra Bingham (Partner at…

Oval Medical’s partner Solize Corporation will exhibit and present at the InnoPack 2015 conference in Tokyo (April 22-24th) in conjunction with the CPhI event held at TokyoBigSight. Representatives from Oval and Solize will be present to demonstrate the Oval autoinjectors and collaboration opportunities. Oval Medical has been attending and exhibiting at a number of conferences…

April 2015 Oval Medical completes Innovate UK (formerly The Technology Strategy Board) Smart Award Grant for development of manufacturing equipment for their novel container closure system. Oval Medical has developed bespoke sealing equipment for the drug container in collaboration with 3P Limited; this is a key manufacturing step for its leading edge auto injector. Commenting…

March 2015 Oval Medical recently completed a £1.5m rights issue for the development of the manufacturing process for its novel autoinjector. The autoinjector facilitates the delivery of the new generation of biologics by eliminating issues including glass breakage, drug contamination and variable injection times. This equipment will form part of the manufacturing process for clinical…